The opportunities for product innovation arising from this new legislation combined with protection of consumer interest in respect of controlling misleading advertising, while at the same time promoting public health, are noteworthy. But such opportunities needed to be evaluated against the burden on industry to undertake significant research activity into these claims and to present a scientific

substantiation to satisfy the procedure for approval.

The EU-funded REDICLAIM project considered these issues in relation to 'reduction of disease risk' claims. As the project comes to an end, this webinar will present the project findings and give you the opportunity to ask questions of our expert speakers.

The session will include:

An introduction to the REDICLAIM project

Ensuring successful health claim applications

Health claims as promoters of new innovative food products?

The NHCR and issues with the regulatory framework

Modelling to predict the health and economic impact of 'reduction in disease risk claims'

After registering, you will receive a confirmation email containing information about joining the webinar.

How to Join our mailing list:
Please sign up here to receive email updates about the publication of the REDICLAIM project recommendations and further papers, reports and presentations: http://eepurl.com/cGHCc1

Please feel free to forward this invitation to anyone who you feel might be interested in the webinar.

With best wishes, Monique
Understanding the impact of legislation on "reduction of disease risk" claims on food and drinks

The FP7 EU funded rediclaim project seeks to understand the way in which the European Regulation (EC) No. 1924/2006 of the European Parliament and of the Council of 20 December 2006 on nutrition and health claims made on foods and associated legislation, has had and continues to have an impact on the substantiation and use of "reduction of disease risk" claims on food and drinks.

The overall aims of rediclaim are to achieve effective compliance with better regulation and to contribute to the enhancement of innovative and competitive products.

The rediclaim consortium is uniquely qualified to achieve the project's objectives. The research teamsacross the consortium differ with regard to their core disciplines and commonly used research methods, combining expertise in law, economics, food science, business, marketing, nutrition and public health. The rediclaim consortium members are also members of the complementary CLYMBOL consortium (KBBE.2012.2.1-01: Role of health-related symbols and claims in consumer behaviour).

Call:

HEALTH.2013.4.1-2: Interactions between EU legislation and health research and/or innovation and the effects of its application and implementation on health research and/or innovation. FP7-HEALTH-2013-INNOVATION-1.